INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update
The Board of International Biotechnology Trust plc (the Company) announces the following unquoted portfolio event.
SV Fund VI's latest estimation values the Company's investment at $37.7m (£27.5m), an uplift of $6.2m (£4.5m) on the preceding valuation of $31.5m (£23.0m) which was included in the Company's Net Asset Value (NAV) calculation for 25 January 2021.
In line with the Company's accounting policy, valuation movements are reflected in the next reported NAV. Therefore, the increase in NAV to be reported today, as at 26 January 2021, will be £4.5m or 11.2 pence per share.
Enquiries:
Telephone: 020 7421 7070
Email: IBT-IR@svhealthinvestors.com
SV Health Managers LLP
Fund Manager
27 January 2021